1-04-2025, 19:00

Anaqua Announces Leadership Change in Japan and the Broader Asia-Pacific Region

Notified -
Globe Newswire1-04-2025, 19:00
22-01-2025, 20:00

Kids Help Phone Launches acceleratorKHP Globally during Davos 2025

Notified -
Globe Newswire22-01-2025, 20:00
20-01-2025, 19:07

Deriv recognised as “Most Innovative Broker - MEA 2025”

Notified -
Globe Newswire20-01-2025, 19:07
15-01-2025, 22:00

STAR Systems International Acquires V Track ID to Propel Innovation in Tolling Industry

Notified -
Globe Newswire15-01-2025, 22:00
12-11-2024, 21:15

Aptean Unveils Aptean AppCentral: A Revolutionary AI-Embedded Platform Enabling Businesses to Scale and Grow
Globe Newswire12-11-2024, 21:15
30-10-2024, 17:30

XPENG Now on Fortune China's "Tech 50" and "China 500" Lists
Globe Newswire30-10-2024, 17:30
24-09-2024, 22:24

At the Yacht Club de Monaco a promising future in the ecological and economic transition of yachting
Globe Newswire24-09-2024, 22:24
11-06-2024, 01:33

London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024
Globe Newswire11-06-2024, 01:33
11-06-2024, 01:33

London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024

Notified -
Globe Newswire11-06-2024, 01:33
22-05-2024, 12:36

MetaHomes Celebrates Art and Innovation with World-Renowned Light Painting Artist, Roy Wang
Globe Newswire22-05-2024, 12:36
15-04-2024, 19:00

London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami
Globe Newswire15-04-2024, 19:00
15-04-2024, 19:00

London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami

Notified -
Globe Newswire15-04-2024, 19:00